NCT00124930

Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer

A Randomized Double-blind, Parallel Group Study Comparing Olanzapine (Zyprexa) With Haloperidol (Novo-peridol) for the Relief of Nausea and Vomiting in Patients With Advanced Cancer

• Status: Terminated
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: Alberta Health services · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the efficacy and safety of Haldol (haloperidol) and olanzapine in the control of chronic nausea with advanced cancer patients who have failed first line antiemetic therapy.

Detailed description

The purpose of this study is to compare the efficacy and safety of haloperidol and olanzapine in the control of chronic nausea with advanced cancer patients who have failed first line antiemetic therapy.

Conditions

• Nausea
• Neoplasms

Interventions

Type	Name	Description
DRUG	Olanzapine
DRUG	Haldol

Timeline

• Start date: 2005-05-01
• Primary completion: 2008-06-01
• Completion: 2008-06-01
• First posted: 2005-07-29
• Last updated: 2012-01-19

Locations

1 site across 1 country: Canada